Quinovare is a high-tech enterprise specialized in the R&D, manufacturing and sales of needle-free injector in various fields with 100,000-degree sterile production workshops and 10,000-degree sterile laboratory. Our factory is equipped with a self-designed automated production line and top-class machinery. We can produce 150,000 injectors and 15 million pieces of consumables annually. Besides R&D ability, Quinovare also pays great attention to product design and has won the Germany Reddot Design Awards, Japan Good Design Award and China Red Star Awards. We have applied for 23 patents, including the international invention patent. Many clinical trials were completed, proving good medication absorption brought by needle-free injector. In 2019, a study lead by IDF West Pacific Region president Prof. Ji was published in a branch journal of the Lancet which received high recognition from numerous diabetologists. It helps to lay a solid foundation for needle-free injector's popularization in China and abroad.

Adhering to the principle of care, patience and sincerity, Quinovare ensures each injector's high quality. We hope needle-free injection technology benefits more patients and improves patient’s life quality by reducing injection pain. As always, Quinovare strives tirelessly to realize the vision of “a better world with needle-free diagnosis and therapies”.